Cowley Benjamin, Kirjanen Svetlana, Partanen Juhani, Castrén Maija L
Brain Work Research Centre, Finnish Institute of Occupational HealthHelsinki, Finland; Cognitive Brain Research Unit, Cognitive Science, Institute of Behavioral Sciences, University of HelsinkiHelsinki, Finland.
City of Helsinki Education Department Helsinki, Finland.
Front Hum Neurosci. 2016 Jul 12;10:353. doi: 10.3389/fnhum.2016.00353. eCollection 2016.
Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability and a variant of autism spectrum disorder (ASD). The FXS population is quite heterogeneous with respect to comorbidities, which implies the need for a personalized medicine approach, relying on biomarkers or endophenotypes to guide treatment. There is evidence that quantitative electroencephalography (EEG) endophenotype-guided treatments can support increased clinical benefit by considering the patient's neurophysiological profile. We describe a case series of 11 children diagnosed with FXS, aged one to 14 years, mean 4.6 years. Case data are based on longitudinal clinically-observed reports by attending physicians for comorbid symptoms including awake and asleep EEG profiles. We tabulate the comorbid EEG symptoms in this case series, and relate them to the literature on EEG endophenotypes and associated treatment options. The two most common endophenotypes in the data were diffuse slow oscillations and epileptiform EEG, which have been associated with attention and epilepsy respectively. This observation agrees with reported prevalence of comorbid behavioral symptoms for FXS. In this sample of FXS children, attention problems were found in 37% (4 of 11), and epileptic seizures in 45% (5 of 11). Attention problems were found to associate with the epilepsy endophenotype. From the synthesis of this case series and literature review, we argue that the evidence-based personalized treatment approach, exemplified by neurofeedback, could benefit FXS children by focusing on observable, specific characteristics of comorbid disease symptoms.
脆性X综合征(FXS)是遗传性智力残疾的最常见原因,也是自闭症谱系障碍(ASD)的一种变体。FXS患者群体在合并症方面差异很大,这意味着需要采用个性化医疗方法,依靠生物标志物或内表型来指导治疗。有证据表明,定量脑电图(EEG)内表型指导的治疗可以通过考虑患者的神经生理特征来提高临床疗效。我们描述了一个包含11名被诊断为FXS的儿童的病例系列,年龄在1至14岁之间,平均年龄为4.6岁。病例数据基于主治医生对包括清醒和睡眠EEG特征在内的合并症状的纵向临床观察报告。我们将该病例系列中的合并EEG症状制成表格,并将它们与关于EEG内表型及相关治疗选择的文献联系起来。数据中最常见的两种内表型是弥漫性慢振荡和癫痫样EEG,它们分别与注意力和癫痫有关。这一观察结果与报道的FXS合并行为症状的患病率一致。在这个FXS儿童样本中,37%(11名中的4名)存在注意力问题,45%(11名中的5名)有癫痫发作。发现注意力问题与癫痫内表型相关。通过对这个病例系列的综合分析和文献综述,我们认为以神经反馈为代表的循证个性化治疗方法可以通过关注合并疾病症状的可观察到的具体特征,使FXS儿童受益。